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Abstract
Respiratory syncytial virus (RSV) is the major cause of viral respiratory infections in children. Our previous study showed that
the RSV infection induced lung epithelial cell cycle arrest, which enhanced virus replication. To address the mechanism of
RSV-induced cell cycle arrest, we examined the contribution of RSV-matrix (RSV-M) protein. In this report, we show that in
both the A549 cell line and primary human bronchial epithelial (PHBE) cells, transfection with RSV-M protein caused the cells
to proliferate at a slower rate than in control cells. The cell cycle analysis showed that RSV-M protein induced G1 phase
arrest in A549 cells, and G1 and G2/M phase arrest in PHBE cells. Interestingly, RSV-M expression induced p53 and p21
accumulation and decreased phosphorylation of retinoblastoma protein (Rb). Further, induction of cell cycle arrest by RSV-
M was not observed in a p53-deficient epithelial cell line (H1299). However, cell cycle arrest was restored after transfection
of p53 cDNA into H1299 cells. Taken together, these results indicate that RSV-M protein regulates lung epithelial cell cycle
through a p53-dependent pathway, which enhances RSV replication.
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Introduction
Respiratory syncytial virus (RSV) is a major cause of respiratory
tract infection in infants and young children worldwide [1,2]. In
the US, approximately 125,000 children are hospitalized annually
with a 2% of mortality rate [3]. However, there are no effective
vaccines for RSV. Importantly, RSV infection in early life has
been associated with subsequent development and exacerbations
of asthma [4,5].
RSV, a member of paramyxoviridae family, is an enveloped
virus with a single-stranded negative sense RNA genome, which
replicates in the cytoplasm of host cells. The RSV genome encodes
nine structural proteins and two non-structural proteins, compris-
ing the envelope glycoproteins (F, G, and SH), the nucleocapsid
proteins (N, P, and L), the nucleocapsid-associated proteins (M2-1
and M2-2), and the matrix protein (M) [6].
In our previous study we showed that RSV infection induced
epithelial cell cycle arrest [7]. In addition to participating as an
integral part the virus particle, RSV-M protein is shuttled to the
host cell nucleus at an early stage of virus replication, where it can
inhibit cellular transcription [8,9,10,11]. Therefore, we hypothe-
sized that RSV-M protein played a key role in the RSV-induced
cell cycle inhibition and therefore enhanced virus replication.
To further delineate the mechanism of RSV-M protein
induction of cell cycle arrest, we examined the contribution of
the tumor suppressor protein p53, which plays a pivotal role in cell
cycle arrest [12]. Once activated, p53 binds cellular DNA and
induces expression of several genes including GADD45, IGF-BP3
and WAF1/CIP1 which encodes p21. p21 is a key molecule in cell
cycle regulation binds to and inhibits the activity of cyclin-
dependent kinase (CDK) complexes, thereby inhibiting Rb
phosphorylation. The phosphorylation of Rb is a well-described
regulator of the cell cycle. Therefore, over expression of p53 causes
arrest of cell growth [13].
Virus infections are known to activate the p53 pathway.
Infection of influenza A virus, Epstein–Barr virus (EBV),
adenovirus, HIV-1 and minute virus induce host cell accumulation
of p53, cell cycle arrest and apoptosis [14,15,16,17,18,19,20].
Over-expression of p53 also is observed in chronic hepatitis C
virus infected patients, suggesting an impaired cell cycle pro-
gression that lead to worsening of the disease [21]. However, some
viral proteins, particularly in DNA viruses, form complexes with
p53 and reduce effective p53 levels [22]. Our previous study
showed that RSV infection induced lung epithelial cell cycle arrest
which subsequently enhanced RSV replication [7].
Furthermore, viral proteins such as non-structural protein of
influenza A virus, large T antigen of the human polyoma virus,
JC virus large T protein, human parvovirus B19 NS1 protein
and avian reovirus p17 protein induce cell cycle arrest in G1 or
G2 phase through p53 or p21 accumulation [23,24,25,26,27].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38052Interestingly, the fusion protein of RSV (RSV-F) triggers p53-
dependent apoptosis [25]. In our current study, our data
showed that RSV-M protein induced lung epithelial cell cycle
arrest through the accumulation of p53 protein.
Material and Methods
Plasmid Construction and Transfection
The eukaryotic expression vector pSG-5 was purchased from
Stratagene (Santa Clara, CA). The RSV-M protein gene open
reading frame (ORF) was amplified from RNA isolated from
RSV-A2-infected cells by RT-PCR with the forward primer: 59-
TGCGGATCCATGGAAACATACGTGAAC-39; the reverse
primer: 59-TGCGGATCCTTAATCTTCCATGGGTTTG-39.
After digestion with restriction enzyme BamHI, the RSV-M gene
was cloned into pSG-5 (pSG-M) using standard techniques.
Sequencing was performed to verify the fidelity on the cloned
cDNA. pcDNA3.1-p53 plasmid expressing the wild type human
p53 was kindly provided by Dr. Michael Resnick (NIEHS, NIH).
For transfections, DOTAP liposomal transfection reagent (Roche,
Indianapolis, IN) was used for transfection DNA into A549 cells.
Nucleofector kit (Lonza, Walkersville, MD) was used for trans-
fection into PHBE cells with program W-001 according to the
manufacturer’s instructions. The plasmid expressing GFP
(pmaxGFP) (Lonza, Walkersville, MD) was used to evaluate
transfection efficacy.
Cells and Cell Culture Reagents
Primary human bronchial epithelial (PHBE) cells and serum-
free bronchial epithelial basal medium with growth supplements
were purchased from Lonza (Walkersville, MD). The human
alveolar epithelial cell line A549 and human p53-deficient lung
cancer cell line H1299 were purchased from American Type
Culture Collection (ATCC Number: CCL-185 & CRL-5803),
which were grown as a monolayer in Dulbecco’s modified Eagle’s/
Ham’s F-12 medium with 5% fetal calf serum and 1% penicillin-
streptomycin at 37uC in a 5% CO2 humidified incubator. H1299
is a human lung lymph node-derived non-small cell carcinoma cell
line which has a homozygous partial deletion of the TP53 gene
and does not express p53 protein. The p53 expressing H1299
(p53
+/+) cell line was derived from H1299 after transfection with
pcDNA3.1-p53 plasmid. G418 (Sigma-Aldrich, St. Louis, MO)
selection was used to isolate stably expressing cells with the wild
type p53 protein. Nutlin-3, a cell cycle regulatory compound
through accumulation of p53, was purchased from Sigma-Aldrich
(St. Louis, MO), diluted in captisol (CyDex, Kansas City, MO),
and was used at of 10 mM.
Virus and Infections
The human RSV subtype A2 was grown and titrated by
standard plaque assay in human epithelial cell line HEp-2 as
previously described [28]. After cells reached 70% confluency,
they were infected with RSV at the indicated multiplicity of
infection (MOI). Cells were then harvested at various times and
were used for analysis.
Cell Proliferation Assay and Cell Cycle Analysis
For cell proliferation assays, A549 and PHBE cells were
transfected with pSG-M, and pSG-5 as vector control. Cells
were treated with nutlin-3 as positive control for p53-induced
cell cycle arrest. Cells were treated captisol alone as the vehicle
control. At indicated time-point post-treatment, cells were
washed and resuspended in phosphate-buffered saline (PBS).
Total cell numbers at each day were determined with
a hemocytometer, and dead cells were identified by trypan
blue staining. Cell cycle analysis was performed by flow
cytometry. Briefly, 4 hr prior to harvesting cells were treated
with 10 mM bromodeoxyuridine (BrdU) (BD Bioscience, San
Jose, CA). Cells were then fixed with 70% ethanol for 30 min
at 220uC and then labeled with fluorescein isothiocyanate-
conjugated anti-BrdU antibody according to the manufacturer’s
instructions (BD Biosciences, San Jose, CA). The cell cycle
properties were then analyzed using BrdU incorporation and 7-
Amino-actinomycin D (7-AAD) (BD Biosciences, San Jose, CA)
staining. Flow cytometry was carried out on a Becton-Dickinson
FACSort flow cytometer, and quantification of cell cycle
distribution was determined using either CellQuest or Modfit
software (BD Biosciences, San Jose, CA).
Western Blot and Antibodies
For western blot analysis, cells were washed twice with PBS and
were then lysed in Laemmli sample buffer containing 2.5% b-
mercaptoethanol. The total cellular proteins were denatured and
reduced by heating at 95uC for 5 min. Protein concentration was
then determined by the Bio-Rad protein assay (Bio-Rad, Hercules,
CA). Proteins were resolved by SDS-polyacrylamide gel electro-
phoresis and were electrotransferred onto nitrocellulose mem-
branes. The membranes were probed with respective primary
antibodies and horseradish peroxidase-conjugated secondary
antibody according to the manufacturer’s instructions. Primary
antibodies were anti-p53 (DO-1), anti-Phospho-p53 (serine-15),
anti-p21, anti-phospho-Rb (p780) and anti-glyceraldehyde-3-
phosphate dehydrogenase (anti-GAPDH) (Cell Signaling, Dan-
vers, MA); anti-RSV (Fitzgerald Industries, Concord, MA).
Monoclonal antibody C781 is specific for M protein [9]. The
enhanced chemiluminescence (ECL) western blot detection system
was then used to visualize the immunoblotted proteins (GE
Healthcare, Piscataway, NJ). Quantification of the bands were
performed using ImageJ software.
Quantitative RT-PCR
Total RNA was isolated with TRIzol RNA isolation reagent
(Invitrogen, Carlsbad, CA) following the manufacturer’s instruc-
tions. RNA was reverse transcribed into first-strand cDNA using
Superscript reverse transcriptase (Invitrogen, Carlsbad, CA) with
oligo (A) primer. The cDNA was then amplified by real-time PCR
(RT-PCR) as previously described [7]. All RT-PCR results were
normalized according to GAPDH before analysis. Primer
sequences used in RT-PCR were as follows: GAPDH (forward)
59-GGACCTGACCTGCCGTCTAG-39 (reverse) 59-TAGCC-
CAGGATGCCCTTGAG-39; RSV-NS1 (forward) 59-AGA-
GATGGGCAGCAATTCAT-39 (reverse) 59-CACAAACA-
CAATGCCATTCA-39; RSV-NS2 (forward) 59-
ATCAATTCAGCCAACCCAAC-39(reverse) 59-
ATGTGGCCTGTTTTTCATCA-39; RSV-P (forward) 59-
GGCAAGACTCAGGAATGAGG-39 (reverse) 59-GTTGGAT-
GATTGGGTTGGTT-39; RSV-M (forward) 59-AAAGACGAT-
GACCCTGCATC-39 (reverse) 59-TGGTAAATTTGCTGGG-
CATT-39; RSV-G (forward) 59-
CAACCCCAACATACCTCACC-39 (reverse) 59-GTGGATTG-
CAGGGTTGACTT-39; RSV-N (forward) 59-AGGATTGTT-
TATGAATGCCTATGGT-39 (reverse) 59-
GCTTTTGGGTTGTTCAATATATGGTAC-39; RSV-L (for-
ward) 59-CAGCCAAATCCAACCAACTT-39 (reverse) 59-
AATTCCCTGCTCCTTCACCT-39 and p53 (forward) 59-
TCAACAAGATGTTTTGCCAACTG-39 (reverse) 59-
ATGTGCTGTGACTGCTTGTAGATG-39.
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Statistical analysis was performed on cell proliferation assays,
cell cycle analysis, quantification of bands in western blots, RT-
PCR and plaque assays. The values are standard errors of the
means based on Student’s t test. Significance values (P values) of
less than 0.05 were interpreted as statistically significant.
Results
RSV-M Protein Expression Inhibits Epithelial Cells
Proliferation
To assess the role of RSV-M in cell cycle regulation, we first
determined the expression of RSV-M in A549 and PHBE cells by
western blot analysis (Fig. 1 A). The data showed that a protein of
approximately 29 KDa was expressed after transfection, which
reacted with a specific mAb to RSV-M protein [10]. The
transfection efficiencies are 90–100% in A549 cell and 70–80%
in PHBE according to the GFP expressing plasmid (data not
shown).
Next, to determine the effect of RSV-M protein expression on
cell proliferation, we transfected both A549 and PHBE cells with
the vector alone or with the vector carrying RSV-M. After
indicated times post transfection, cells were quantified by
enumeration using a hemocytometer (Fig. 1B). The results showed
that pSG-M transfected cells replicated at a significantly slower
rate than cells transfected with the vector alone (pSG-5) or treated
with the vehicle control (captisol) (Fig. 1B). The cells treated with
nutlin-3 were used as a positive control, which have similar
proliferation rate as pSG-M transfected cells. The number of dead
cells did not have significant difference, and were ,1% in all
samples.
M Protein Expression Induces Cell Cycle Arrest
Since there was a significant reduction in cell proliferation, we
next performed cell cycle analysis using BrdU incorporation and
flow cytometry. Data showed that in A549 cells pSG-M trans-
fection induced a significant G1 phase arrest (G1 phase:
51.462.2% vs. 44.761.3%) (Fig. 2 A). However, in PHBE cells,
both G1 and G2/M phase arrest were observed (G1 phase:
67.160.5% vs. 54.561.0%; G2 phase: 15.561.2% vs. 8.660.9%)
(Fig. 2B). The data showed that RSV-M alone was sufficient for
induction of cell cycle arrest.
M Protein Expression Activates the p53 Pathway
To first determine whether RSV infection induced p53 we
performed a kinetic study in infected A549 cells. Western blot
analysis showed that RSV infection induced p53 in a time
dependent manner (Fig. 3A). This induction, we reasoned, maybe
in part due to RSV-M protein expression. To investigate whether
p53 induction and activation of downstream signaling molecules
was in part due to RSV M expression, we performed transfection
studies.
A549 cells and PHBE cells (Fig. 3, panel B) were transfected
with pSG-M and pSG-5 (vector control). At indicated time-points,
cell extracts were prepared and were subjected to western blot
analysis using mAb to p53 (DO-1) and phospho-p53 (serine-15).
Data showed that RSV infection increased p53 expression and
phosphorylation in a time-dependent manner.
Figure 1. RSV-M protein expression inhibits cell proliferation. Panel A, western blot analysis, with specific anti RSV-M monoclonal antibody
(C781) in cells transfected with pSG-5 plasmid alone (Con) or pSG-5 plasmid carrying RSV-M cDNA (pSG-M). Panel B, sub-confluent monolayer
(approximately 10% confluency) of A549 cells (left panel) and PHBE cells (right panel) were transfected with pSG-M and pSG-5 (vector control). Cells
were treated with nutlin-3 (positive control) and captisol alone (vehicle control). Cell replication was then determined by counting the cell numbers
using a hemocytometer. Error bars indicate standard error of the mean (SEM) (n=3).
doi:10.1371/journal.pone.0038052.g001
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Rb. Data showed that p21 accumulated significantly starting at
24 hr and reached maximal level at 72 hr post transfection (Fig. 3B
and C). The level of Rb phosphorylation was diminished after
RSV-M protein transfection, suggesting that downstream signals
are involved in cell cycle arrest. The level of RSV-M protein
expression was coincident with the maximal effect on changes in
the level and the phosphorylation state of the signaling molecules.
Quantification of the bands was performed using the ImageJ
software, and the data showed significant time-dependent changes
after RSV-M transfection as compared to vector control (Fig. 3C).
p53 is Necessary for RSV-M Protein Induced Cell Cycle
Arrest
Infection with several different viruses causes p53 activation,
which is critical for cell cycle regulation. We next investigated the
role of p53 in the RSV-M protein induced cell cycle arrest. To this
end, a p53-deficient cell line (H1299) was used for transfection
studies.
Figure 2. RSV-M protein induces cell cycle arrest in both A549 and PHBE cells. Cells were transfected with pSG-M or pSG-5 (vector control).
The distribution of cell cycle phases of the transfected A549 cells (panel A) and PHBE cells (panel B) were determined by flow cytometry at 2 days
post-transfection. The cell cycle properties were analyzed using BrdU incorporation and 7-AAD staining. The left panels are FACS data, and the right
panels are the statistical analysis of each cycle from 3 separate experiments. Error bars are the standard error of the mean (n=3). *p-values,0.05.
doi:10.1371/journal.pone.0038052.g002
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wild-type (wt) p53 (pCDNA3.1-p53) or with the vector alone
(pCDNA3.1). The stable H1299 p53
+/+ and H1299 cell lines were
selected with G418. The expression of p53 was then assessed by
western blot analysis (Fig. 4A). Transfections studies were
performed with pSG-M and the empty vector. The data from
Figure 3. RSV Infection and RSV-M protein expression induce p53 activation. Panel A, A549 cells were infected with RSV at MOI of 5 PFU/
cell. Cell extracts were prepared at indicated times and used in western blot using anti p53 mAb (DO-1). A549 cells (panel B, left) or PHBE cells (panel
B, right) were transfected with pSG-M (M) or pSG-5 (V). At indicated time points, total cell extracts were prepared and were used in western blot
analysis. The specific anti-total p53 (DO-1), anti-phospho-p53 at serine-15 residue, anti-p21, anti-phospho-Rb at residue 780 and anti-RSV-M protein
antibody were used to identify the respective molecules. Anti-GAPDH antibody was used as an internal control. Panel C, qualification of p53,
phospho-p53, p21, and phospho-Rb was performed by using ImageJ software. Error bars are the standard error of the mean (n=3). *p-values,0.05.
doi:10.1371/journal.pone.0038052.g003
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alone did not induce the cell cycle arrest (G1 phase: 43.065.1%
vs. 45.963.5%) (Fig. 4B). On the other hand, in H1299 p53
+/+
cells, the pSG-M transfection induced the G1 phase arrest (G1
phase: 53.3610.3% vs. 39.962.7%) (Fig. 4C). These results
showed that RSV-M protein induced cell cycle arrest is dependent
on p53 expression.
Wild Type p53 Expression Enhances RSV Replication
Replication of several viruses is enhanced by p53 [29,30].
Therefore, we next examined the effect of p53 on RSV replication.
We tested the RSV transcription and replication in H1299 and
H1299 p53
+/+ cell lines. First, RSV transcription level was
determined by RT-PCR utilizing the RSV-NS1, NS2, N, P, M, G
and L gene-specific primers. RT-PCR results showed that at 24 hr
post infection RSV genes mRNA levels are approximately 10 fold
higher in H1299 p53
+/+ cell line than H1299 cells (Fig. 5A). The
enhancement increases to approximately 20 fold at 48 hr post
infection (Fig. 5A). Next, to directly measure the effects of p53
expression on RSV replication, virus yield was determined by
plaque assay. Plaque assay results showed that virus titer was
approximately 20 fold higher in H1299 p53
+/+ cell line (Fig. 5B).
Further, induction of p53 in A549 and PHBE cells with nutlin-3
significantly enhanced transcription of RSV NS1 and G genes.
(Fig. 5C). The results suggest that the p53 protein enhances RSV
replication.
Discussion
A number of viruses affect the cell cycle to subvert host-cell
functions and increase their own replication. The cell cycle arrest
during virus infection has adverse effects on lung epithelium and
contributes to impede lung repair, which is associated with airways
injury and bronchiolitis [31,32]. This study for the first time
demonstrates that the RSV-M protein causes the epithelial cell
cycle arrest by a p53 dependent pathway.
Modulation of cell growth is a common feature of virus
infections and can be induced by specific viral proteins [26,27,33].
The current study demonstrated that the epithelial cells transiently
expressing RSV-M protein grew at a slower rate than cells
transfected with an empty vector (Fig. 1). Effect of RSV-M protein
Figure 4. p53 is necessary for RSV-M-induced cell cycle arrest. Panel A, western blot analysis of H1299 cells transfected with a plasmid
carrying the wild type p53 cDNA. After isolation of stable transformants, H1299 cells (panel B) and H1299 p53
+/+ cells (panel C) were transfected with
pSG-M (RSV-M) and pSG-5 (vector). The cycle phase distribution was then analysed by flow cytometry at 48 hr post transfection. The right panels are
the statistical analysis of each cycle from 3 separate experiments. Error bars are the standard error of the mean (n=3). *p-values,0.05.
doi:10.1371/journal.pone.0038052.g004
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regulator (Fig. 1). The effect of RSV-M protein on cell cycle was
maximal at day three post transfection which was coincident with
the peak of p53 accumulation (Fig. 3), this suggests that RSV-M
protein affects cell cycle through a p53-dependent pathway.
Despite the increase in p53 expression, there was no significant
difference in the number of dead cells between RSV-M protein
expressing cells or cells transfected with vector alone, suggesting
that the changes in cell numbers is not due to cell death either by
necrosis or apoptosis (data not shown).
To further determine the effect of p53 on RSV-M protein
regulation of cell cycle, we used H1299 cells which are deficient in
p53 expression. Transient transfection studies using H1299 cells
showed that p53 was required for the RSV-M protein-induced cell
cycle regulation (Fig. 4). RSV-M protein is known to be
transferred to the nucleus where it can induce cellular transcrip-
tional perturbations. Since p53 is a cell stress response factor, it is
likely that transcriptional perturbation induced by RSV-M protein
regulate p53 expression.
Under non-stressed conditions, p53 is a short-lived protein
[34]. However, when p53 is activated by a variety of stress
stimuli including DNA damage and virus infections [35], it is
rescued from degradation and then translocated into the nucleus.
In the nucleus, it can be phosphorylated on serine-15 by ataxia
ATM (telangiectasia-mutated) or ATR (ATM and Rad3-related)
proteins which causes the initiation of a cascade of subsequent
post-translational modifications [36]. One important p53 targets
is p21 cip1/waf1 which is a direct mediator of cell cycle arrest at
the G1 and G2/M phase. In turn, p21 can complex with specific
Cdks resulting in inhibition of Rb phosphorylation. The
phosphorylation of Rb is a well-described regulator of cell
proliferation by controlling progression through the cell cycle
restriction points [37]. Alteration in Rb phosphorylation is widely
used as an indicator of G1/S phase perturbations. In our
experiments, results of western blots showed the expression of
RSV-M protein induced accumulation of p21 and reduction in
Rb phosphorylation (Fig. 3).
The cell cycle analysis on RSV-infected cells or RSV-M
protein transfected cells showed differences between A549 cell
Figure 5. p53 expression enhances RSV replication. Panel A, H1299 and H1299 p53
+/+ cells were infected with RSV at MOI of 1 PFU/cell. After
24 and 48 hours, total cellular RNA was isolated. The RSV gene transcription levels between the p53-expressing and non-expressing cells were
normalized to GAPDH and compared at the respective time points. Panel B, cells were prepared as in panel A but to measure virus replication
a standard plaque assay was performed (left panel). The number of plaques and the titer of the virus was then determined (right panel). Panel C, A549
and PHBE cells were treated with nutlin-3 or captisol alone (vehicle control). After 48 hours, cells were infected with RSV at MOI of 1 PFU/cell. After
24 hr, relative changes of NS1 and G genes were determined. The error bars are standard error of the mean from three independent assays.
doi:10.1371/journal.pone.0038052.g005
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cycle was arrested in the G1 (Fig. 2A), whereas both G1 and
G2 phases were arrested in the PHBE cells (Fig. 2B). Our
current data obtained in infected A549 cells are consistent with
the cell cycle arrest by RSV infection that we previously
reported [7]. However, in PBHE cells, in addition to G2/M
arrest RSV-M transfection also induced G1 arrest. At this point
we do not know the exact reason for this discrepancy but it
may be due to more complex events that take place during
virus infection as compared to transfection with one protein
alone. Also, during transfection, soluble M protein may be
present at higher levels as compared to the levels during RSV
infections where it can form complexes with other viral proteins
[38]. Alternatively, it may be due to differences in the nature of
each PHBE cell lot, which are isolated from different donors.
These differences include but are not limited to sex, age and the
genetic backgrounds of each donor. Results of further studies
comparing these variables are required to provide clearer
answers for the discrpencies in using different lots of PHBE
cells.
The effect of p53 on virus replication has been previously
reported. p53 protein promotes adenoviral and CMV replica-
tion and limits poliovirus and vesicular stomatitis virus
replication [29,30,39,40]. In this study, we demonstrated that
p53 expression significantly enhanced the RSV replication,
although the exact underling mechanism is still unclear. It is
possible that inhibition of the cell cycle results in increased
availability of necessary components for viral assembly. It is also
possible that p53 alone or in addition to other transcription
factors act as an enhancing factor for viral replication through
a transcriptional effect.
It appears that the nuclear shuttling of viral proteins affecting
host cell biological activity is an important mechanism to enhance
virus replication. Research on nuclear shuttling protein p17 of
avian reovirus showed that it facilitates virus replication by
initiation of p53-dependent G2/M arrest [24,33]. In addition,
EBV nuclear antigen 3C targets p53 and modulates apoptotic
activities, and HIV-1 nuclear protein Vpr induces cell cycle arrest
[41,42,43].
Chulu et al. reported that during reovirus infection, the cell
cycle blockade promotes virus growth by diverting the cellular
machinery required for normal cell replication [24]. During HIV-
1 and CMV infections, cell cycle is arrested at G1 or G2/M phase
which creates a favorable environment for viral replication
[43,44,45]. Furthermore, Julia et al. reported that RSV fusion
protein triggered p53-dependent apoptosis [25].
In conclusion, our data suggests that RSV infections and
expression of the M protein profoundly affect cell cycle through
a p53-dependent pathway. This suggests that any environmental
factor that can increase p53 such as air pollution, smoking and
ozone could enhance viral replication (Fig. 6). In addition,
regulation of cell cycle during RSV infection may play a role in
damage and recovery during such infections. It is important to
note that RSV is the most common virus associated with severe
bronchiolitis [46]. Further experiments are underway to de-
termine the interaction between RSV-M protein and p53
regulation on RSV replication and respiratory damage.
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